Copenhagen Pancreatic Cancer Study (COPAN)
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 8,000
- 试验地点
- 1
- 主要终点
- Overall survival
研究概览
简要总结
The primary objective of the Copenhagen Pancreatic Cancer (COPAN) study is to describe the real-world population of patients with pancreatic cancer (PC). Larger sample of longitudinal real-world data provides a unique opportunity for comprehensive exploration of the diagnostic and treatment journey for individuals diagnosed with PC and allows to investigate treatment outcomes and associated prognostic factors. Furthermore, the study aims to identify determinants of treatment management and treatment outcomes, including patient-reported outcomes.
详细描述
The study objective is to describe the real-world population of patients with pancreatic cancer by collecting longitudinal data that facilitates a more rigorous understanding of the PC. This research project will catalog different elements of a patient's diagnostic and treatment journey and identify unmet needs of patients with PC.
The study aims to:
- To compile detailed demographic information of patients with PC.
- To document and analyze the clinical and disease characteristics at the time of diagnosis and beyond.
- To track various treatment modalities employed, including surgery, chemotherapy, and radiation therapy.
- To assess short-term and long-term outcomes, including survival rates, complications, and quality of life.
- To identify prognostic and predictive factors within the real-world cohort.
8. To investigate the impact of PC and treatment on patients' quality of life.
4 Study Design This study of patients with PC will employ both a prospective, observational design and retrospective design to capture real-world data relating to health status and/or the delivery of health care routinely collected from a variety of sources. Data will be collected longitudinally, allowing for a dynamic analysis of the disease trajectory.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Histologically confirmed pancreatic cancer
排除标准
- 未提供
研究组 & 干预措施
Patients with PC are referred to Comprehensive Pancreatic Cancer Center at Herlev Hospital
结局指标
主要结局
Overall survival
时间窗: 3 years
次要结局
未报告次要终点
研究者
Inna Chen, MD
MD
Herlev Hospital
